from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1716/-

LFCtreatmentdescriptionclass of inhibitor

-0.191

Amikacinug/mL Amikacintranslation

-0.375

Cap5-10ug/mL Capreomycintranslation

-0.391

Rox10-50 ug/mL Roxithromycintranslation

-0.169

SM2-5 ug/mL Streptomycintranslation

-1.060

Tet5-10 ug/mL Tetracyclinetranslation

1.129

Rif0.2-5ug/mL Rifampicintranscription

0.115

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.362

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.709

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.147

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.122

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.121

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.870

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.132

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.232

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.291

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.242

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.619

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.170

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.276

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.397

KCN5-20 ug/mL Potassium cyaniderespiration

-0.410

NaN30.2-2 mM Sodium aziderespiration

0.456

Nigericin50 uM Nigericinrespiration

0.612

TRC10-150 ug/mL Triclosanrespiration

-0.136

TRZ10-25 ug/mL Thioridazinerespiration

0.695

Valinomycin0.5-10 uM Valinomycinrespiration

1.061

ZnSO42 mM ZnSO4respiration

0.739

menadione6-10 ug/mL Menadionerespiration

0.233

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.114

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.023

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.497

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.628

NRP_1Non-replicating persistence stage 1dosRassociated

0.047

Amp0.2mg/mL AmpicillincellWall

0.574

Cephalexin20-100 ug/mL CephalexincellWall

0.317

Cerulenin0.32-5 ug/mL CerulenincellWall

1.299

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.679

EMB10-20 ug/mL EthambutolcellWall

-0.313

Eta12-40 ug/mL EthionamidecellWall

-0.491

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.037

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.240

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.231

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.270

BZA0.12 mg/mL BenzamidearomaticAmides

0.388

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.177

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.199

H2O24 mM hydrogen peroxideDNAdamaging

0.602

Levo10 ug/mL LevofloxacinDNAdamaging

-1.097

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.340

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

-2.160

UVUV-irradiationDNAdamaging

0.278

ARP41-4 ug/mL Antitubercular compound ARP4?

0.175

Antimycin12.5-50 ug/mL Antimycin A?

0.256

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.012

PA_110-50 ug/mL Antitubercular compound PA-1?

0.253

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.326

PA8240.2-2 ug/mL PA-824?

0.222

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.439

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.028

Verapamil50 uM Verapamil?

0.040

mercaptoethanol2 mM 2-Mercaptoethanol?

0.423

methoxatin10-20 ug/mL Methoxatin?